CervoMed Inc.
CRVO
$9.56
$0.131.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -348.36% | -349.69% | -650.10% | -793.71% | -44.62% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.33% | 102.72% | 104.00% | 109.17% | -242.67% |
| Change in Net Operating Assets | -264.19% | -415.76% | -68.66% | 142.51% | 78.98% |
| Cash from Operations | -205.51% | -157.07% | -121.89% | -96.62% | -84.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 142.03% | -- | -- | -- | -- |
| Cash from Investing | 142.03% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.28% | 5,629.86% | 5,629.86% | 5,629.86% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.90% | -- |
| Cash from Financing | -92.05% | 316.16% | 316.16% | 311.88% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.04% | 9.98% | -67.39% | -147.55% | 326.27% |